Indian Journal of Clinical Biochemistry

, Volume 20, Issue 2, pp 162–165 | Cite as

Free radical injury and antioxidant status in patients with benign prostate hyperplasia and prostate cancer



Reactive oxygen species and other free radicals are known to be the mediators of phenotypic and genotypic changes that lead from mutation to neoplasia. There are some primary antioxidants such as glutathione peroxidase (GPx), glutathione S-transferases (GSTs) and reduced glutathione, which protect against callular and molecular damage caused by the reactive oxygen metabolites (ROMs). The present study was conducted to determine the level of malondialdehyde (MDA), as an index of lipid peroxidation, along with the GPx, GSTs activities and level of reduced glutathione in 45 prostate cancer (PC) patients, 55 benign prostate hyperplasia (BPH) patients as compared to the controls. Significant higher levels of MDA and GSTs activities in the serum, (P<0.005) and significant lower levels of reduced GSH concentration and GPx activity in blood haemolysates (P<0.05) of PC and BPH patients were observed as compared to the controls. The relatively higher GSTs activity and low level of reduced GSH may be due to the response of increased reactive oxygen metabolites production in the blood. The higher MDA and lower GPx activities may be inadequate to detoxify high levels of H2O2 into H2O leading to the formation of the*OH radical followed by MDA. This result hypothesizes that oxidant-antioxidant imbalance may be one of the major factor responsible for the development of prostate cancer and benign prostate hyperplasia.

Key Words

Antioxidant enzymes Benign prostate hyperplasia Prostate cancer Reactive oxygen species 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ray, G., Batra, S., Shukla, N.K., Deo, S., Raina, V., Ashok, S. and Husain, S.A. (2000) Lipid peroxidation free radical production and antioxidant status in breast cancer. Breast Cancer Res. Treat. 59, 163–70.PubMedCrossRefGoogle Scholar
  2. 2.
    Zheng, Q.S., Sun, X.L. and Wang, C.H. (2002) Re-differentiation of human gastric cancer cells induced by ascorbic acid and sodium selenite. Biomed. Environ. Sci. 15, 223–232.PubMedGoogle Scholar
  3. 3.
    Olusi, S.O. (2002) Obesity is an independent risk factor plasma lipid peroxidation and depletion of erythrocyte cytoprotective enzymes in humans. Int. J. Obes. Relat. Metab. Disord. 26, 1159–64PubMedCrossRefGoogle Scholar
  4. 4.
    Zima, T., Spicka, I., Stipek, S., Crkovska, J., Platenik, J., Merta, M. and Tesar, V. (1996) Antioxidant enzymes and lipid peroxidation in patients with multiple myeloma. Neoplasma 43, 69–73.PubMedGoogle Scholar
  5. 5.
    Sabitha, K.E. and Shyamaladevi, C.S. (1999) Oxidant and antioxidant activity changes in patients with oral cancer and treated with radiotherapy. Oral Oncol. 35, 273–277.PubMedCrossRefGoogle Scholar
  6. 6.
    Ghalia, A.A., Rabboh, N.A., el, Shalakani, A., Seada, L. and Khalifa, A. (2000) Estimation of glutathione S-transferase and its Pi isoenzyme in tumor tissues and sera of patients with ovarian cancer. Anticancer Res. 20, 1229–1235.PubMedGoogle Scholar
  7. 7.
    Kehrer, J.P. (1993) Free radicals as mediators of tissue injury and disease. Critical reviews in toxicology, 23, 21–48.PubMedCrossRefGoogle Scholar
  8. 8.
    Guven, M., Ozturk, B., Sayal, A., Ozeturk, A. and Ulutin, T. (1999) Lipid peroxidation and antioxidant system in the blood of cancerous patients with metastasis. Cancer Biochem. Biophys. 17, 155–162.PubMedGoogle Scholar
  9. 9.
    Yoshioka, T., Kawada, K., Shimada, T. and Mori, M. (1979) Lipid peroxidation in maternal and cord blood and protective mechanisms against activated oxygen toxicity in the blood. Am. J. Obster. Gynecology. 135, 372–376.Google Scholar
  10. 10.
    Habig, W.H., Pabst, M.J. and Jakoby W.B. (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249, 7130–7139.PubMedGoogle Scholar
  11. 11.
    Beutler, E., Duron, O., and Kelly, B.M. (1961) Improved method for the determination of blood glutathione. J. Lab. and Clin. Med. May, 882–888.Google Scholar
  12. 12.
    Hayes, J.D. and Pulford, D.J. (1995) The Glutathione S-transferases (GST) supergene family: regulation of GST and contriburion of the isoenzymes to cancer prevention and drug resistance. Cret. Rev. Biochem. Mol. Biol. 30, 445–600.CrossRefGoogle Scholar
  13. 13.
    Armstrong, R.N. (1997) Structure, catalytic mechanism and evolution of the glutathione transferases. Chem. Res. Toxicol. 10, 2–18.PubMedCrossRefGoogle Scholar
  14. 14.
    Kitly, C.G. and Doyle, S.M. (1996). Glutathione S-transferases as a biomarkers of organ viability and damage. In: Vermeulen, N.P.E., Mulder, G.J., Nieuwenhuyse, H., Peters, W.H.M. and Van Bladerns, P.J., editors, Glutathione S-transferases: structure function and clinical implication. London: Taylor and Francis. pp.249–58.Google Scholar
  15. 15.
    Lee, W.H., Morton, R.A., Epstein, J.I., Brooks, J.D., Campbell, P.A., Bova, G.S., Hsieh, W.S., Isaacs, W.B. and Nelson, W.G. (1994) Cytidine methylation of regulatory sequences near the piclass glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA, 91 (24), 11733–11737.PubMedCrossRefGoogle Scholar

Copyright information

© Association of Clinical Biochemists of India 2005

Authors and Affiliations

  1. 1.Department of UrologySanjay Gandhi Post Graduate Institute of Medical SciencesLucknowIndia

Personalised recommendations